Rachel Tsunemoto Hislop

Director/Board Member at Abilita Therapeutics, Inc.

Finance

Health Technology

Profile

Rachel Tsunemoto Hislop is currently working as a Director at Abilita Therapeutics, Inc. and as a Principal at Two Bear Capital Operations LLC since 2020.
She completed her undergraduate degree from Massachusetts Institute of Technology.

Rachel Tsunemoto Hislop active positions

Companies	Position	Start
Two Bear Capital Operations LLC Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital Operations LLC (Two Bear Capital) is venture capital firm founded in 2019 by Mike Goguen. The firm is headquartered in Whitefish, Montana.	Private Equity Investor	2019-12-31
Abilita Therapeutics, Inc. Abilita Therapeutics, Inc. BiotechnologyHealth Technology Abilita Therapeutics, Inc. is a biotechnology company that focuses on discovering and developing drugs that target challenging human membrane proteins with high medical impact, such as GPCRs, ion channels, and transporters. The company is based in San Diego, CA. The company's internal drug discovery pipeline is focused on treating cancer and chronic pain. Abilita Bios EMP™ platform fuels research collaborations with pharmaceutical and biotech partners. The company was founded in 2014 by Mauro Mileni, who has been the CEO since 2014.	Director/Board Member	-

All active positions of Rachel Tsunemoto Hislop

Training of Rachel Tsunemoto Hislop

Massachusetts Institute of Technology

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rachel Tsunemoto Hislop's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Two Bear Capital Operations LLC Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital Operations LLC (Two Bear Capital) is venture capital firm founded in 2019 by Mike Goguen. The firm is headquartered in Whitefish, Montana.	Finance
Abilita Therapeutics, Inc. Abilita Therapeutics, Inc. BiotechnologyHealth Technology Abilita Therapeutics, Inc. is a biotechnology company that focuses on discovering and developing drugs that target challenging human membrane proteins with high medical impact, such as GPCRs, ion channels, and transporters. The company is based in San Diego, CA. The company's internal drug discovery pipeline is focused on treating cancer and chronic pain. Abilita Bios EMP™ platform fuels research collaborations with pharmaceutical and biotech partners. The company was founded in 2014 by Mauro Mileni, who has been the CEO since 2014.	Health Technology